[ Price : $8.95]
FDA accepts for priority review a Boehringer Ingelheim NDA for zongertinib (BI 1810631) for treating certain adult patients with u...[ Price : $8.95]
FDA approves a Mirum Pharmaceuticals NDA for Ctexli (chenodiol) for treating adults with cerebrotendinous xanthomatosis.[ Price : $8.95]
Pharmaceutical Research and Manufacturers of America says FDA should revise its recommendations for sponsors requesting meetings c...[ Price : $8.95]
In another blow to FDAs institutional knowledge, CBER deputy director Celia M. Witten leaves the agency amid a deepening staff exo...[ Price : $8.95]
Three Arnall Golden Gregory attorneys describe steps foreign drug and medical device companies can take to prepare for what they s...[ Price : $8.95]
HHS appoints Robert Fox Foster as FDAs next chief counsel.[ Price : $8.95]
FDA staff tell Reuters a potentially bogus list of words that cant be used in external communications under a Trump Executive Orde...[ Price : $8.95]
The Texas federal judge hearing the consolidated cases against FDA over its final rule on laboratory-developed tests promises a ru...